SkinHealth Systems Inc. Gain (Loss) on Disposition of Assets
SkinHealth Systems Inc. (SKIN) reported Gain (Loss) on Disposition of Assets of -$5.24 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-03-01
- SkinHealth Systems Inc. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was -$542.00K.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was -$3.71M.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for the quarter ending 2022-06-30 was -$159.00K.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for the quarter ending 2022-03-31 was -$829.00K.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for fiscal 2022 was -$5.24M.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for fiscal 2021 was $0.00.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for fiscal 2020 was -$110.00K.
- SkinHealth Systems Inc. gain (loss) on disposition of assets for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$4.25M derived: sum of 2 quarters · filed 2023-03-01 | -$4.41M derived: sum of 3 quarters · filed 2023-03-01 | -$5.24M 10-K · filed 2023-03-01 |
| 2022-09-30 | -$3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.87M derived: sum of 2 quarters · filed 2022-11-09 | -$4.70M 10-Q · filed 2022-11-09 | -$4.70M derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$988.00K 10-Q · filed 2022-08-09 | -$988.00K derived: sum of 3 quarters · filed 2023-03-01 | -$988.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | -$829.00K 10-Q · filed 2022-05-10 | -$829.00K derived: sum of 2 quarters · filed 2023-03-01 | -$829.00K derived: sum of 3 quarters · filed 2023-03-01 | -$829.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | -$133.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$133.00K derived: sum of 3 quarters · filed 2023-03-01 | -$85.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$133.00K derived: sum of 2 quarters · filed 2023-03-01 | -$85.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$85.00K derived: sum of 2 quarters · filed 2023-03-01 | -$110.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $23.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$25.00K 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |